Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 8Sanofi-Aventis Canada Inc.
01 42652976
02 42790197
01 8SARILUMAB
01 8SOLUTION
01 42027-06-01
02 42031-01-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2027-06-01
Date Granted : 2015-08-11
Brand Name : KEVZARA
Patent Number : 2652976
Filing Date : 2007-06-01
Strength per Unit : 150 mg / 1.14 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2027-06-01
Date Granted : 2015-08-11
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2027-06-01
Date Granted : 2015-08-11
Brand Name : KEVZARA
Patent Number : 2652976
Filing Date : 2007-06-01
Strength per Unit : 200 mg / 1.14 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2027-06-01
Date Granted : 2015-08-11
Patent Expiration Date : 2031-01-07
Date Granted : 2017-12-12
Brand Name : KEVZARA
Patent Number : 2790197
Filing Date : 2011-01-07
Strength per Unit : 150 mg / 1.14 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-01-07
Date Granted : 2017-12-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-01-07
Date Granted : 2017-12-12
Brand Name : KEVZARA
Patent Number : 2790197
Filing Date : 2011-01-07
Strength per Unit : 200 mg / 1.14 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-01-07
Date Granted : 2017-12-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-06-01
Date Granted : 2015-08-11
Brand Name : KEVZARA
Patent Number : 2652976
Filing Date : 2007-06-01
Strength per Unit : 150 mg / 1.14 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2027-06-01
Date Granted : 2015-08-11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-01-07
Date Granted : 2017-12-12
Brand Name : KEVZARA
Patent Number : 2790197
Filing Date : 2011-01-07
Strength per Unit : 150 mg / 1.14 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-01-07
Date Granted : 2017-12-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-06-01
Date Granted : 2015-08-11
Brand Name : KEVZARA
Patent Number : 2652976
Filing Date : 2007-06-01
Strength per Unit : 200 mg / 1.14 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2027-06-01
Date Granted : 2015-08-11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-01-07
Date Granted : 2017-12-12
Brand Name : KEVZARA
Patent Number : 2790197
Filing Date : 2011-01-07
Strength per Unit : 200 mg / 1.14 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-01-07
Date Granted : 2017-12-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
